Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson's disease

被引:30
|
作者
Si, Xiaoli [1 ,2 ]
Dai, Shaobing [3 ]
Fang, Yi [1 ]
Tang, Jiahui [1 ]
Wang, Zhiyun [1 ]
Li, Yaolin [1 ]
Song, Zhe [1 ]
Chen, Ying [1 ]
Liu, Yi [1 ]
Zhao, Guohua [1 ,2 ,4 ]
Zhang, Baorong [1 ]
Pu, Jiali [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 4, Int Inst Med, Sch Med,Dept Neurol, Yiwu 322000, Zhejiang, Peoples R China
[3] Zhejiang Univ, Womens Hosp, Sch Med, Dept Anesthesiol, Hangzhou 310009, Zhejiang, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Dept Neurol, N1 Ave, Yiwu 322000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; Glymphatic system; Aquaporin-4; Matrix metalloproteinase-9; Metabolomics; BETA-DYSTROGLYCAN; SUBSTANTIA-NIGRA; ALPHA; MODEL;
D O I
10.1016/j.jare.2023.03.004
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: The glymphatic system offers a perivascular pathway for the clearance of pathological proteins and metabolites to optimize neurological functions. Glymphatic dysfunction plays a pathogenic role in Parkinson's disease (PD); however, the molecular mechanism of glymphatic dysfunction in PD remains elusive. Objective: To explore whether matrix metalloproteinase-9 (MMP-9)-mediated 13-dystroglycan (13 -DG) cleavage is involved in the regulation of aquaporin-4 (AQP4) polarity-mediated glymphatic system in PD. Methods: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD and A53T mice were used in this study. The glymphatic function was evaluated using ex vivo imaging. TGN-020, an AQP4 antagonist, was administered to investigate the role of AQP4 in glymphatic dysfunction in PD. GM6001, an MMP-9 antagonist, was administered to investigate the role of the MMP-9/13-DG pathway in regulating AQP4. The expression and distribution of AQP4, MMP-9, and 13 -DG were assessed using western blotting, immunofluorescence, and co-immunoprecipitation. The ultrastructure of basement membrane (BM)astrocyte endfeet was detected using transmission electron microscopy. Rotarod and open-field tests were performed to evaluate motor behavior. Results: Perivascular influx and efflux of cerebral spinal fluid tracers were reduced in MPTP-induced PD mice with impaired AQP4 polarization. AQP4 inhibition aggravated reactive astrogliosis, glymphatic drainage restriction, and dopaminergic neuronal loss in MPTP-induced PD mice. MMP-9 and cleaved 0 -DG were upregulated in both MPTP-induced PD and A53T mice, with reduced polarized localization of 0DG and AQP4 to astrocyte endfeet. MMP-9 inhibition restored BM-astrocyte endfeet-AQP4 integrity and attenuated MPTP-induced metabolic perturbations and dopaminergic neuronal loss. Conclusion: AQP4 depolarization contributes to glymphatic dysfunction and aggravates PD pathologies, and MMP-9-mediated 0 -DG cleavage regulates glymphatic function through AQP4 polarization in PD, which may provide novel insights into the pathogenesis of PD. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:125 / 136
页数:12
相关论文
共 50 条
  • [31] β-DYSTROGLYCAN CLEAVAGE BY MATRIX METALLOPROTEINASE-2/-9 DISTURBS AQUAPORIN-4 POLARIZATION AND INFLUENCES BRAIN EDEMA IN ACUTE CEREBRAL ISCHEMIA
    Yan, W.
    Zhao, X.
    Chen, H.
    Zhong, D.
    Jin, J.
    Qin, Q.
    Zhang, H.
    Ma, S.
    Li, G.
    NEUROSCIENCE, 2016, 326 : 141 - 157
  • [32] Silencing matrix metalloproteinase 9 exerts a protective effect on astrocytes after oxygen-glucose deprivation and is correlated with suppression of aquaporin-4
    Li, Siyi
    Li, Yanhua
    Huang, Shuxuan
    Fan, Binglin
    Wei, Junjie
    Ouyang, Liefeng
    Chen, Zhi
    Jiang, Bingjian
    NEUROSCIENCE LETTERS, 2020, 731
  • [33] Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson's disease
    Liu, Chuan Ze
    Guo, Da Shuai
    Ma, Jian Jun
    Dong, Lin Rui
    Chang, Qing Qing
    Yang, Hong Qi
    Liang, Ke Ke
    Li, Xiao Huan
    Yang, Da Wei
    Fan, Yong Yan
    Gu, Qi
    Chen, Si Yuan
    Li, Dong Sheng
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [34] Association of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 With Endothelial Dysfunction, Cardiovascular Disease Risk Factors and Thrombotic Events in Children With End-stage Renal Disease
    Gheissari, Alaleh
    Meamar, Rokhsareh
    Abedini, Amin
    Roomizadeh, Peyman
    Shafiei, Mohammad
    Samaninobandegani, Zahra
    Tabrizi, Zhale
    Mahmoudi, Farhad
    Merrikhi, Alireza
    Tavana, Esfandiar Najafi
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (03) : 169 - 177
  • [35] Overexpression of matrix metalloproteinase-9 (MMP9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer's disease
    Kaminari, Archontia
    Giannakas, Nikolas
    Tzinia, Athina
    Tsilibary, Effie C.
    SCIENTIFIC REPORTS, 2017, 7
  • [36] Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease
    Archontia Kaminari
    Nikolas Giannakas
    Athina Tzinia
    Effie C. Tsilibary
    Scientific Reports, 7
  • [37] Potential Contribution of Hypoxia-Inducible Factor-1α, Aquaporin-4, and Matrix Metalloproteinase-9 to Blood-Brain Barrier Disruption and Brain Edema After Experimental Subarachnoid Hemorrhage
    Wang, Zhong
    Meng, Cheng-Jie
    Shen, Xu-Ming
    Shu, Zhang
    Ma, Chao
    Zhu, Guo-Qing
    Liu, Hui-Xiang
    He, Wei-Chun
    Sun, Xue-Bo
    Huo, Lei
    Zhang, Jian
    Chen, Gang
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 (01) : 273 - 280
  • [38] Non-proteolytically-mediated inhibition of collagen gel contractile activity of smooth muscle cells by matrix metalloproteinase-9
    Defawe, OD
    Kenagy, RD
    Choi, C
    Wan, SY
    Clowes, AW
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A77 - A77
  • [39] Nuclear factor-κB plays an important role in Tamarixetin-mediated inhibition of matrix metalloproteinase-9 expression
    Shaji, Sanu K.
    Drishya, G.
    Sunilkumar, Damu
    Pandurangan, Nanjan
    Kumar, Geetha B.
    Nair, Bipin G.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 893
  • [40] Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth
    Buisson-Legendre, N
    Bernard, P
    Bobichon, H
    Emonard, H
    Schneider, C
    Maquart, FX
    Haye, B
    Hornebeck, W
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (03) : 634 - 640